Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/8/2025

Meniere's Disease Management

Introduction to Management

  • The American Academy of Otolaryngology-Head and Neck Surgery recommends first-line treatment for patients with Meniere's disease to include lifestyle modifications, diuretics, and/or betahistine, with progression to intratympanic steroids for those not responsive to conservative treatment 1
  • The American Academy of Otolaryngology-Head and Neck Surgery suggests that betahistine and diuretics have shown benefit in observational studies, though evidence quality is moderate 1

Diagnostic Considerations

  • Bilateral Meniere's disease may occur in 10-25% of cases over time, suggesting the need for more conservative approaches 2
  • Meniere's disease can be confused with vestibular migraine, BPPV, or vestibular neuritis, making careful attention to symptom patterns essential 2
  • The following conditions can be distinguished from Meniere's disease based on their distinguishing features:
Condition Distinguishing Features
Vestibular migraine May have shorter (<15 min) or longer (>24 hr) attacks; less likely to have hearing loss; often has history of migraine; photophobia common
BPPV Brief vertigo (seconds) triggered by position changes; no hearing loss
Vestibular neuritis Prolonged vertigo (days); no hearing loss
Labyrinthitis Prolonged vertigo with sudden non-fluctuating hearing loss
Vestibular schwannoma Chronic imbalance rather than episodic vertigo; progressive non-fluctuating hearing loss
Stroke/ischemia May have other neurological symptoms; usually no associated hearing loss or tinnitus
  • A detailed history focusing on vertigo characteristics, duration, and associated symptoms, audiometric testing to document fluctuating low- to mid-frequency sensorineural hearing loss, video/electronystagmography to evaluate vestibular function, electrocochleography to measure electrical responses of cochlea and auditory nerve, and MRI of brain to rule out other causes and potentially visualize endolymphatic hydrops, are recommended by the American Academy of Otolaryngology-Head and Neck Surgery 2

Treatment Options

  • Intratympanic steroids can be used for patients with active Meniere's disease not responsive to noninvasive treatment, with benefits including improved vertigo control, improved quality of life, and faster return to work, although risks include hearing loss, eardrum perforation, and persistent imbalance 1
  • Positive pressure therapy should not be prescribed as it has been shown to be ineffective 1
  • Vestibular rehabilitation/physical therapy should not be recommended for managing acute vertigo attacks but may be beneficial during the intercritic period 1
  • Surgical options include intratympanic steroids for anti-inflammatory effect, intratympanic gentamicin for chemical labyrinthectomy (can affect hearing), endolymphatic sac decompression as a hearing-sparing procedure, vestibular nerve section as a hearing-sparing procedure, and labyrinthectomy as an ablative procedure (sacrifices remaining hearing), as stated by the American Academy of Otolaryngology-Head and Neck Surgery 2

Lifestyle and Dietary Modifications

  • A low-sodium diet (1500-2300 mg daily) is recommended, but patients should be monitored for hyponatremia, especially elderly patients or those with comorbidities 1
  • Limiting alcohol consumption and caffeine intake is also recommended as part of lifestyle modifications 1
  • Identifying and managing triggers (stress, allergies, etc.) is recommended, as stated by the American Academy of Otolaryngology-Head and Neck Surgery 2

Patient Expectations and Disease Course

  • The disease course can be unpredictable with symptoms that may naturally fluctuate, making treatment efficacy assessment challenging 2
  • Patient expectations should be managed, considering the unpredictable nature of attacks and their potential impact on quality of life 2
  • Meniere's disease is defined by two or more spontaneous attacks of vertigo, each lasting 20 minutes to 12 hours, audiometrically documented fluctuating low- to mid-frequency sensorineural hearing loss in the affected ear, and fluctuating aural symptoms (hearing loss, tinnitus, or fullness) in the affected ear, according to the American Academy of Otolaryngology-Head and Neck Surgery 2, 1
  • A definitive diagnosis requires at least two spontaneous vertigo attacks with documented fluctuating hearing loss in the affected ear before, during, or after one of the episodes, as specified by the American Academy of Otolaryngology-Head and Neck Surgery 2, 1
  • Typically affects adults in their 40s-70s, can be unilateral or bilateral (25-40% of cases), and may include drop attacks (Tumarkin's Otolithic Crisis) in later stages, as reported by the American Academy of Otolaryngology-Head and Neck Surgery 2
  • Symptoms are episodic and unpredictable, with vertigo lasting 20 minutes to 12 hours, hearing loss initially affecting low to mid-frequencies, tinnitus, and aural fullness, according to the American Academy of Otolaryngology-Head and Neck Surgery 2
  • Drop attacks, or Tumarkin's Otolithic Crisis, are sudden falls without warning, typically occurring in later stages of the disease, according to the American Academy of Otolaryngology-Head and Neck Surgery 2, 1
  • The disease course can be progressive or non-progressive, with vertigo attacks decreasing over time, but hearing loss often progressing, and quality of life significantly impacted by unpredictable attacks, causing anxiety, depression, and social isolation, as reported by the American Academy of Otolaryngology-Head and Neck Surgery 2
  • Symptoms of Meniere's disease can significantly impact quality of life, causing anxiety, depression, and social isolation, as reported by the American Academy of Otolaryngology-Head and Neck Surgery 2
  • Patients should be encouraged to keep a symptom journal to identify potential triggers, join support groups for knowledge and emotional support, and understand the unpredictable and fluctuating nature of the disease, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 2
  • Clinicians should document resolution, improvement, or worsening of vertigo frequency and severity, tinnitus intensity, hearing loss progression, and quality of life impact, according to the American Academy of Otolaryngology-Head and Neck Surgery 2
  • Regular audiometric testing to track hearing loss progression, documenting changes in vertigo frequency and severity, and assessing impact on quality of life, are necessary for follow-up, according to the American Academy of Otolaryngology-Head and Neck Surgery 2

REFERENCES

1

clinical practice guideline: ménière's disease executive summary. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

2

clinical practice guideline: ménière's disease. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020